Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Science (London, England : 1979)|February 1, 1987
Oral absorption of the somatostatin analogue SMS 201-995: theoretical and practical implicationsH S Fuessl, J Domin, S R BloomDiabetes Research (Edinburgh, Scotland)|April 1, 1987
Linkage analysis between maturity-onset type diabetes in young people (MODY) and HLAH S Fuessl, S Scholz, E D Albert, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 1, 1987
Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patientsH S Fuessl, G Williams, T E Adrian, et al.Alimentary Pharmacology & Therapeutics|February 1, 1987
Chronic administration of the somatostatin analogue SMS 201-995 does not lead to endogenous antibody formationH S Fuessl, J Domin, J V Anderson, et al.Digestion|January 1, 1987
Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in manH S Fuessl, G Carolan, G Williams, et al.Digestive Diseases and Sciences|December 1, 1985
Plasma peptide YY (PYY) in dumping syndromeT E Adrian, R G Long, H S Fuessl, et al.Alimentary Pharmacology & Therapeutics|August 1, 1987
The effect of a long-acting somatostatin analogue (SMS 201-995) on intermediary metabolism and gut hormones after a test meal in normal subjectsH S Fuessl, J M Burrin, G Williams, et al.Surgery|June 1, 1987
Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in manT E Adrian, A P Savage, H S Fuessl, et al.Gastroenterology|November 1, 1985
Human distribution and release of a putative new gut hormone, peptide YYT E Adrian, G L Ferri, A J Bacarese-Hamilton, et al.Pageof 1